132 related articles for article (PubMed ID: 31444962)
1. Unstimulated high-sensitive thyroglobulin is a powerful prognostic predictor in patients with thyroid cancer.
Giovanella L; Castellana M; Trimboli P
Clin Chem Lab Med; 2019 Dec; 58(1):130-137. PubMed ID: 31444962
[TBL] [Abstract][Full Text] [Related]
2. Unstimulated highly sensitive thyroglobulin in follow-up of differentiated thyroid cancer patients: a meta-analysis.
Giovanella L; Treglia G; Sadeghi R; Trimboli P; Ceriani L; Verburg FA
J Clin Endocrinol Metab; 2014 Feb; 99(2):440-7. PubMed ID: 24285679
[TBL] [Abstract][Full Text] [Related]
3. Serial post-surgical stimulated and unstimulated highly sensitive thyroglobulin measurements in low- and intermediate-risk papillary thyroid carcinoma patients not receiving radioactive iodine.
Kashat L; Orlov S; Orlov D; Assi J; Salari F; Walfish PG
Endocrine; 2016 Nov; 54(2):460-466. PubMed ID: 27189148
[TBL] [Abstract][Full Text] [Related]
4. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
5. Multicentre clinical evaluation of the new highly sensitive Elecsys® thyroglobulin II assay in patients with differentiated thyroid carcinoma.
Trimboli P; Imperiali M; Piccardo A; CampennÌ A; Giordani I; Ruggeri RM; Baldari S; Orlandi F; Giovanella L
Clin Endocrinol (Oxf); 2018 Feb; 88(2):295-302. PubMed ID: 28960391
[TBL] [Abstract][Full Text] [Related]
6. Stimulated Thyroglobulin and Thyroglobulin Reduction Index Predict Excellent Response in Differentiated Thyroid Cancers.
Barres B; Kelly A; Kwiatkowski F; Batisse-Lignier M; Fouilhoux G; Aubert B; Dutheil F; Tauveron I; Cachin F; Maqdasy S
J Clin Endocrinol Metab; 2019 Aug; 104(8):3462-3472. PubMed ID: 30785995
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of thyroglobulin measurement with fine-needle aspiration biopsy for lymph node metastases in patients with a history of differentiated thyroid cancer.
Zhang HS; Wang RJ; Fu QF; Gao S; Sun BT; Sun H; Ma QJ
Asian Pac J Cancer Prev; 2014; 15(24):10905-9. PubMed ID: 25605199
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine.
Momesso DP; Vaisman F; Yang SP; Bulzico DA; Corbo R; Vaisman M; Tuttle RM
J Clin Endocrinol Metab; 2016 Jul; 101(7):2692-700. PubMed ID: 27023446
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
[TBL] [Abstract][Full Text] [Related]
10. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.
Giovanella L; Maffioli M; Ceriani L; De Palma D; Spriano G
Clin Chem Lab Med; 2009; 47(8):1001-4. PubMed ID: 19589104
[TBL] [Abstract][Full Text] [Related]
11. Additional value of a high sensitive thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinoma.
Groen AH; Klein Hesselink MS; Plukker JT; Sluiter WJ; van der Horst-Schrivers AN; Brouwers AH; Lentjes EG; Muller Kobold AC; Links TP
Clin Endocrinol (Oxf); 2017 Mar; 86(3):419-424. PubMed ID: 27588675
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
13. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
[TBL] [Abstract][Full Text] [Related]
14. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
15. Does an undetectable rhTSH-stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission?
Klubo-Gwiezdzinska J; Burman KD; Van Nostrand D; Wartofsky L
Clin Endocrinol (Oxf); 2011 Jan; 74(1):111-7. PubMed ID: 21054476
[TBL] [Abstract][Full Text] [Related]
16. Stimulated thyroglobulin values above 5.6 ng/ml before radioactive iodine ablation treatment following levothyroxine withdrawal is associated with a 2.38-fold risk of relapse in Tg-ab negative subjects with differentiated thyroid cancer.
Mousa U; Yikilmaz AS; Nar A
Clin Transl Oncol; 2017 Aug; 19(8):1028-1034. PubMed ID: 28258491
[TBL] [Abstract][Full Text] [Related]
17. Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.
Golger A; Fridman TR; Eski S; Witterick IJ; Freeman JL; Walfish PG
J Endocrinol Invest; 2003 Oct; 26(10):1023-31. PubMed ID: 14759077
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.
Miyauchi A; Kudo T; Miya A; Kobayashi K; Ito Y; Takamura Y; Higashiyama T; Fukushima M; Kihara M; Inoue H; Tomoda C; Yabuta T; Masuoka H
Thyroid; 2011 Jul; 21(7):707-16. PubMed ID: 21649472
[TBL] [Abstract][Full Text] [Related]
19. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.
Fugazzola L; Mihalich A; Persani L; Cerutti N; Reina M; Bonomi M; Ponti E; Mannavola D; Giammona E; Vannucchi G; di Blasio AM; Beck-Peccoz P
J Clin Endocrinol Metab; 2002 Jul; 87(7):3201-8. PubMed ID: 12107225
[TBL] [Abstract][Full Text] [Related]
20. Early detection of progressive disease using thyroglobulin doubling-time in metastatic differentiated thyroid carcinoma treated with radioactive iodine.
Zhang X; Higuchi T; Tomonaga H; Lamid-Ochir O; Bhattarai A; Nguyen-Thu H; Taketomi-Takahashi A; Hirasawa H; Tsushima Y
Nucl Med Commun; 2020 Apr; 41(4):350-355. PubMed ID: 32032192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
